{"id":25915,"date":"2025-04-14T09:01:46","date_gmt":"2025-04-14T09:01:46","guid":{"rendered":"https:\/\/medexperts.pro\/?p=25915"},"modified":"2025-04-14T09:27:15","modified_gmt":"2025-04-14T09:27:15","slug":"metas-antitrust-trial-to-put-mark-zuckerberg-serial-witness-to-the-test-again","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=25915","title":{"rendered":"Meta\u2019s Antitrust Trial to Put Mark Zuckerberg, Serial Witness, to the Test Again"},"content":{"rendered":"
<\/div>\n

Meta\u2019s chief has grown accustomed to tough questioning in courts and hearings, but an antitrust trial starting Monday could be more grueling, experts said.<\/p>\n

\n
\n
\n

Seven years ago, Mark Zuckerberg, the chief executive of Meta, testified for the first time in Congress<\/a>. After a two-week boot camp by his lawyers to prep him, he answered questions in three back-to-back-to-back hearings over two days in a baptism by fire.<\/p>\n

Mr. Zuckerberg, 40, has had even more practice since then. He has appeared before Congress eight times and testified in court at least twice, more than any of his peers at the biggest tech companies. He has defended his company, previously known as Facebook, on issues such as privacy, child safety<\/a> and the spread of disinformation<\/a>.<\/p>\n

As early as Monday, Mr. Zuckerberg will again take the hot seat, this time as the marquee witness in the Federal Trade Commission\u2019s landmark lawsuit<\/a> accusing Meta of breaking antitrust law. Regulators sued the company in the U.S. District Court for the District of Columbia over its acquisitions of Instagram<\/a> and WhatsApp<\/a>, saying it used a \u201cbuy-or-bury strategy\u201d to maintain a monopoly in social media.<\/p>\n

Mr. Zuckerberg\u2019s turn as a serial witness has become a potent symbol of Washington\u2019s growing frustration with the power held by Silicon Valley, fueling attempts to rein in the tech industry. Under President Trump, tech chief executives have cozied up<\/a> to the administration in hopes that regulators will take a softer hand, but so far his appointees have signaled continued scrutiny.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

On Capitol Hill, lawmakers have railed at Mr. Zuckerberg, accusing him of lying and having personal responsibility for various societal harms. Previous tough questioning could help him during his expected seven hours of testimony defending Meta in the antitrust trial, legal experts said.<\/p>\n

\u201cHe seems to be much more aware of the audiences he\u2019s speaking to compared to his earlier years,\u201d said Adam Sterling, associate dean at Stanford Law School. \u201cWhether it\u2019s a deposition or a lawsuit or in front of the Senate, he can actually craft the message to the recipients of it.\u201d<\/p>\n

\n
\n
<\/div>\n
\n
\n
\n

We are having trouble retrieving the article content.<\/p>\n

Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into<\/a>\u00a0your Times account, or\u00a0subscribe<\/a>\u00a0for all of The Times.<\/p>\n

\n<\/div>\n
\n
\n

Thank you for your patience while we verify access.<\/p>\n

Already a subscriber?\u00a0Log in<\/a>.<\/p>\n

Want all of The Times?\u00a0Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

Meta\u2019s chief has grown accustomed to tough questioning in courts and hearings, but an antitrust trial starting Monday could be more grueling, experts said.Seven years ago, Mark Zuckerberg, the chief executive of Meta, testified for the first time in Congress. After a two-week boot camp by his lawyers to prep him, he answered questions in three back-to-back-to-back hearings over two days in a baptism by fire.Mr. Zuckerberg, 40, has had even more practice since then. He has appeared before Congress eight times and testified in court at least twice, more than any of his peers at the biggest tech companies. He has defended his company, previously known as Facebook, on issues such as privacy, child safety and the spread of disinformation.As early as Monday, Mr. Zuckerberg will again take the hot seat, this time as the marquee witness in the Federal Trade Commission\u2019s landmark lawsuit accusing Meta of breaking antitrust law. Regulators sued the company in the U.S. District Court for the District of Columbia over its acquisitions of Instagram and WhatsApp, saying it used a \u201cbuy-or-bury strategy\u201d to maintain a monopoly in social media.Mr. Zuckerberg\u2019s turn as a serial witness has become a potent symbol of Washington\u2019s growing frustration with the power held by Silicon Valley, fueling attempts to rein in the tech industry. Under President Trump, tech chief executives have cozied up to the administration in hopes that regulators will take a softer hand, but so far his appointees have signaled continued scrutiny.On Capitol Hill, lawmakers have railed at Mr. Zuckerberg, accusing him of lying and having personal responsibility for various societal harms. Previous tough questioning could help him during his expected seven hours of testimony defending Meta in the antitrust trial, legal experts said.\u201cHe seems to be much more aware of the audiences he\u2019s speaking to compared to his earlier years,\u201d said Adam Sterling, associate dean at Stanford Law School. \u201cWhether it\u2019s a deposition or a lawsuit or in front of the Senate, he can actually craft the message to the recipients of it.\u201dWe are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":25917,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-25915","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/25915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=25915"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/25915\/revisions"}],"predecessor-version":[{"id":25918,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/25915\/revisions\/25918"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/25917"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=25915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=25915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=25915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}